No recent analyst price targets found for GMTX.
Latest News for GMTX
Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile
SAN FRANCISCO--(BUSINESS WIRE)-- #ASCO--Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GMTX.
U.S. House Trading
No House trades found for GMTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.